These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22442101)

  • 1. Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs.
    Peluso MJ; Lewis SW; Barnes TR; Jones PB
    Br J Psychiatry; 2012 May; 200(5):387-92. PubMed ID: 22442101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal side-effects of antipsychotics in a randomised trial.
    Miller DD; Caroff SN; Davis SM; Rosenheck RA; McEvoy JP; Saltz BL; Riggio S; Chakos MH; Swartz MS; Keefe RS; Stroup TS; Lieberman JA;
    Br J Psychiatry; 2008 Oct; 193(4):279-88. PubMed ID: 18827289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.
    Miller CH; Mohr F; Umbricht D; Woerner M; Fleischhacker WW; Lieberman JA
    J Clin Psychiatry; 1998 Feb; 59(2):69-75. PubMed ID: 9501888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extrapyramidal effects of antipsychotic drugs].
    Kulisevsky J; Otermin P
    Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EPS profiles: the atypical antipsychotics are not all the same.
    Weiden PJ
    J Psychiatr Pract; 2007 Jan; 13(1):13-24. PubMed ID: 17242588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons.
    Haddad PM; Das A; Keyhani S; Chaudhry IB
    J Psychopharmacol; 2012 May; 26(5 Suppl):15-26. PubMed ID: 22057019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine is a major risk factor for antipsychotic induced akathisia, parkinsonism and dyskinesia.
    Maat A; Fouwels A; de Haan L
    Psychopharmacol Bull; 2008; 41(3):5-10. PubMed ID: 18779773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
    Modestin J; Wehrli MV; Stephan PL; Agarwalla P
    Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extrapyramidal side effects of antipsychotic treatment: scope of problem and impact on outcome.
    Tandon R; Jibson MD
    Ann Clin Psychiatry; 2002 Jun; 14(2):123-9. PubMed ID: 12238737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Side effects of antipsychotic drugs. Avoiding and minimizing their impact in elderly patients.
    Saltz BL; Woerner MG; Robinson DG; Kane JM
    Postgrad Med; 2000 Feb; 107(2):169-72, 175-8. PubMed ID: 10689415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1).
    Peluso MJ; Lewis SW; Barnes TR; Jones PB
    Schizophr Res; 2013 Mar; 144(1-3):80-6. PubMed ID: 23313462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Movement disorders associated with neuroleptic treatment.
    Wirshing WC
    J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curaçao Extrapyramidal Syndromes Study II.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Schizophr Res; 1997 Aug; 26(2-3):235-42. PubMed ID: 9323356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidences of extrapyramidal symptoms in patients with schizophrenia after treatment with long-acting injection (depot) or oral formulations of olanzapine.
    Hill AL; Sun B; McDonnell DP
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):216-22. PubMed ID: 23428782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
    Pierre JM
    Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the CATIE trial on treatment: extrapyramidal symptoms.
    Casey DE
    CNS Spectr; 2006 Jul; 11(7 Suppl 7):25-31. PubMed ID: 16816797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.